Cover Image
市場調查報告書

基因編輯/基因工程的全球市場的預測 ∼2021年:CRISPR、TALEN、ZFN,細胞株工程、動物基因工程學、植物基因工程學

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 329686
出版日期 內容資訊 英文 164 Pages
訂單完成後即時交付
價格
Back to Top
基因編輯/基因工程的全球市場的預測 ∼2021年:CRISPR、TALEN、ZFN,細胞株工程、動物基因工程學、植物基因工程學 Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021
出版日期: 2016年10月10日 內容資訊: 英文 164 Pages
簡介

基因編輯的市場預計從2016年到2021年以14.3%的年複合成長率發展,從2016年的28億4000萬美元,成長到2021年的55億4000萬美元的規模。基因編輯的市場,在醫療保健產業和製造業的變化伴隨的大變動旋渦之中,該市場的成長大幅受到這些產業的影響。

本報告提供全球基因編輯/基因工程的市場調查,市場及技術定義和概要,市場成長的各種影響因素及市場機會分析,各技術、用途、終端用戶趨勢與市場規模的變化與預測,各地區及各主要國家趨勢,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 地區分析:各用途的成果
  • 市場規模的成果、預測:各技術
  • 市場規模的成果、預測:各用途
  • 市場規模的成果、預測:各終端用戶
  • 地區概要

第5章 基因編輯/基因工程的全球市場:概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 基因編輯/基因工程的全球市場:各技術

  • 簡介
  • CRISPR
  • TALEN
  • ZFN
  • 反義
  • 其他

第7章 基因編輯/基因工程的全球市場:各用途

  • 簡介
  • 細胞株工程
  • 動物基因工程學
  • 植物基因工程學
  • 其他

第8章 基因編輯/基因工程的全球市場:各終端用戶

  • 簡介
  • 生物科技、醫藥品企業
  • 學術、政府研究機關
  • CRO

第9章 基因編輯/基因工程的全球市場:地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲的會議等
    • 英國
    • 德國
    • 其他
      • 西班牙
      • 義大利
      • 瑞典 & 丹麥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
      • 澳洲等
  • 其他地區
    • 中東
    • 巴西
    • 非洲

第10章 競爭環境

  • 概要
  • 市場佔有率分析
    • 簡介
    • THERMO FISHER SCIENTIFIC, INC.
    • MERCK KGAA
    • HORIZON DISCOVERY GROUP PLC
  • 競爭情形、趨勢
    • 協定、聯盟、合作
    • 產品與服務的投入
    • 收購
    • 擴張
    • 其他
  • 策略基準

第11章 企業簡介

  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA
  • HORIZON DISCOVERY GROUP PLC
  • GENSCRIPT USA INC.
  • SANGAMO BIOSCIENCES, INC.
  • INTEGRATED DNA TECHNOLOGIES, INC.
  • LONZA GROUP LTD.
  • NEW ENGLAND BIOLABS, INC.
  • ORIGENE TECHNOLOGIES, INC.
  • TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
    • 簡介
    • 產品與服務
    • 策略
    • 分析師的見解
    • 發展趨勢
    • MnM的見解等

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 3380

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing a significant transformation, with the changing landscapes of healthcare, and manufacturing industries. The growth of this market is majorly influenced by the dynamics of these industries.

Factors such as rising government funding and growth in the number of genomics projects, high prevalence rate of infectious diseases and cancer among patients, technological advancements, increasing demand for synthetic genes, growing awareness about genomics, and increasing new product launches by industry players are expected to drive the genome editing market in the coming years. Rise in the production of genetically modified crops is also expected to increase the demand for genome editing. However, the high cost of genomic equipment, shortage of trained professionals, and adverse public perception related to genetic research are restraining the growth of the market to a certain extent.

Increasing use of genome editing in specialized/personalized medicine and emerging markets in developing countries like Brazil, China, and India are providing various growth opportunities for players in the genome editing market.

In 2016, North America is expected to account for the largest share of the global genome editing market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America is also projected to have the highest growth rate in the forecast period. Factors such as the development of gene therapy in the U.S.; increasing use of GM crops; prevalence of Alzheimer's disease, dementia, infectious diseases, and cancer in the U.S.; growing availability of research grants and funding, and genome editing standards workshops and conferences are likely to propel the market in North America.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; marketing and promotion; agreements, collaborations, partnerships, and funding; patent approval to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the adaptive security market place.

  • By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
  • By Designation: Director Level: 58%, C-Level: 25%, Others: 17%
  • By Region: North America: 46%, Europe: 31%, APAC: 15%, ROW: 8%

Thermo Fisher Scientific, Inc. (U.S.), Merck KGAA (Germany), and Horizon Discovery Group Plc (U.K.) were prominent players in the global genome editing market in 2015. The other players include, Genscript Biotech Corporation (U.S.), Lonza Group Ltd. (Switzerland), Sangamo Biosciences, Inc. (U.S.), Integrated DNA Technologies, Inc (U.S.), New England Biolabs, Inc. (U.S.), Origene Technologies, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the products and services offered by top players in the genome editing market. The report analyzes the genome editing market by technology, application, and end user
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the genome editing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for genome editing across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the genome editing market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the genome editing market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key Data from Primary Sources
      • 2.2.2.2. Key Industry Insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1. MARKET DATA VALIDATION AND TRIANGULATION
    • 2.3.2. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GENOME EDITING: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: GENOME EDITING MARKET, BY APPLICATION (2016)
  • 4.3. GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021
  • 4.4. GENOME EDITING MARKET SIZE, BY APPLICATION, 2016 VS. 2021
  • 4.5. GENOME EDITING MARKET SIZE, BY END USER, 2016 VS. 2021
  • 4.6. GEOGRAPHICAL SNAPSHOT OF THE GENOME EDITING MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising government funding and growth in the number of genomics projects
      • 5.2.1.2. High prevalence rate of infectious diseases and cancer among patients
      • 5.2.1.3. Technological advancements
      • 5.2.1.4. Increase in demand for synthetic genes
      • 5.2.1.5. Rise in production of genetically modified crops
      • 5.2.1.6. Increasing awareness about genomics
      • 5.2.1.7. New product launches by industry players
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of genomic equipment
      • 5.2.2.2. Adverse public perception related to genetic research
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Use of genome editing in specialized/personalized medicine
      • 5.2.3.2. Emerging markets in developing countries
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Off-target effect of CRISPR
      • 5.2.4.2. Shortage of trained professionals

6. GLOBAL GENOME EDITING/ENGINEERING MARKET, BY TECHNOLOGY

  • 6.1. INTRODUCTION
  • 6.2. CRISPR
  • 6.3. TALEN
  • 6.4. ZFN
  • 6.5. ANTISENSE
  • 6.6. OTHER TECHNOLOGIES

7. GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CELL LINE ENGINEERING
  • 7.3. ANIMAL GENETIC ENGINEERING
  • 7.4. PLANT GENETIC ENGINEERING
  • 7.5. OTHER APPLICATIONS

8. GLOBAL GENOME EDITING/ENGINEERING MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 8.3. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
  • 8.4. CONTRACT RESEARCH ORGANIZATIONS

9. GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Development of gene therapy in the U.S.
      • 9.2.1.2. Increasing use of GM crops
      • 9.2.1.3. Prevalence of Alzheimer's Disease and Other Dementias in the United States
      • 9.2.1.4. Genome editing conferences in the U.S.
      • 9.2.1.5. Rising availability of research grants and funding
      • 9.2.1.6. Genome Editing Standards Workshop in the U.S.
      • 9.2.1.7. Increasing prevalence of cancer
      • 9.2.1.8. Strategic developments in the U.S. market
    • 9.2.2. CANADA
      • 9.2.2.1. Availability of research funding in Canada
      • 9.2.2.2. Rising incidence of cancer
      • 9.2.2.3. GAPP to intensify genomic R&D
  • 9.3. EUROPE
    • 9.3.1. CONFERENCES AND MEETINGS IN EUROPE
    • 9.3.2. U.K.
      • 9.3.2.1. Increased funds, and grants by government bodies
      • 9.3.2.2. 100,000 Genomes Project in U.K.
    • 9.3.3. GERMANY
      • 9.3.3.1. Availability of funding for life science research
      • 9.3.3.2. Conferences/Meetings/ Symposiums/Workshops in Germany
      • 9.3.3.3. ROE
      • 9.3.3.4. Spain's focus on research
      • 9.3.3.5. Growth in the Italian biotech and pharma sectors
      • 9.3.3.6. Growing research investments in Sweden & Denmark
  • 9.4. ASIA-PACIFIC
    • 9.4.1. CHINA
      • 9.4.1.1. High intensity of R&D activities in China
      • 9.4.1.2. Growing focus of global companies on China
    • 9.4.2. JAPAN
      • 9.4.2.1. Involvement of industry players in the Japanese market: significant developments
      • 9.4.2.2. Conferences and symposiums on genetic engineering in Japan
      • 9.4.2.3. Focus on cancer research and treatment
    • 9.4.3. INDIA
      • 9.4.3.1. Emergence of local players in India
      • 9.4.3.2. Growth of the pharmaceutical industry in India
      • 9.4.3.3. Development of bio-clusters to boost India's biotechnology industry
    • 9.4.4. ROAPAC
      • 9.4.4.1. Australia: Availability of financial support for research
      • 9.4.4.2. Genome Asia 100K initiative
      • 9.4.4.3. Crop research initiatives in Asia
  • 9.5. ROW
    • 9.5.1. GENETIC TESTING AND GENOMIC ANALYSIS IN THE MIDDLE EAST
    • 9.5.2. BRAZIL: INVESTMENTS IN RESEARCH AND INNOVATION CENTERS AND CONFERENCES & WORKSHOPS
    • 9.5.3. RISING PREVALENCE OF HIV, CANCER IN AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
    • 10.2.1. INTRODUCTION
    • 10.2.2. THERMO FISHER SCIENTIFIC, INC.
    • 10.2.3. MERCK KGAA
    • 10.2.4. HORIZON DISCOVERY GROUP PLC
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 10.3.2. PRODUCT & SERVICE LAUNCHES
    • 10.3.3. ACQUISITIONS
    • 10.3.4. EXPANSIONS
    • 10.3.5. OTHER STRATEGIES
  • 10.4. STRATEGIC BENCHMARKING

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. THERMO FISHER SCIENTIFIC, INC.
  • 11.2. MERCK KGAA
  • 11.3. HORIZON DISCOVERY GROUP PLC
  • 11.4. GENSCRIPT USA INC.
  • 11.5. SANGAMO BIOSCIENCES, INC.
  • 11.6. INTEGRATED DNA TECHNOLOGIES, INC.
  • 11.7. LONZA GROUP LTD.
  • 11.8. NEW ENGLAND BIOLABS, INC.
  • 11.9. ORIGENE TECHNOLOGIES, INC.
  • 11.10. TRANSPOSAGEN BIOPHARMACEUTICALS, INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. OTHER DEVELOPMENTS, BY COMPANY (2013-2016)
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 2: CRISPR-BASED GENOME EDITING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 3: NORTH AMERICA: CRISPR-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 4: EUROPE: CRISPR-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 5: ASIA-PACIFIC: CRISPR-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 6: TALEN-BASED GENOME EDITING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NORTH AMERICA: TALEN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: EUROPE: TALEN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: ASIA-PACIFIC: TALEN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: ZFN-BASED GENOME EDITING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: NORTH AMERICA: ZFN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: EUROPE: ZFN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: ASIA-PACIFIC: ZFN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: ANTISENSE TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: NORTH AMERICA: ANTISENSE TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: EUROPE: ANTISENSE TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: ASIA-PACIFIC: ANTISENSE TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: OTHER GENOME EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICA: OTHER GENOME EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: EUROPE: OTHER GENOME EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: ASIA-PACIFIC: OTHER GENOME EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 23: GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: EUROPE: GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 26: ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 27: GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: NORTH AMERICA: GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: EUROPE: GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 30: ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 31: GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: EUROPE: GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 34: ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 35: GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: EUROPE: GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 38: ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 40: GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: EUROPE: GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51: ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: GENOME EDITING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 53: NORTH AMERICA: GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 55: NORTH AMERICA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 56: NORTH AMERICA: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57: U.S.: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 58: U.S.: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: U.S.: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 60: INDICATIVE LIST OF PROJECTS FUNDED BY GAPP IN 2014
  • TABLE 61: CANADA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 62: CANADA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 63: CANADA: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 64: PROMINENT EVENTS IN EUROPE
  • TABLE 65: EUROPE: GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: EUROPE: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 67: EUROPE: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 68: EUROPE: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 69: U.K.: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 70: U.K.: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 71: U.K.: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 72: EVENTS IN GERMANY
  • TABLE 73: GERMANY: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 74: GERMANY: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 75: GERMANY: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 76: ROE: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 77: ROE: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 78: ROE: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 79: ASIA-PACIFIC: GENOME EDITING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 80: ASIA-PACIFIC: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 81: ASIA-PACIFIC: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 82: ASIA-PACIFIC: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 83: CHINA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 84: CHINA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 85: CHINA: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 86: CONFERENCES, SYMPOSIA, & WORKSHOPS IN JAPAN (2016)
  • TABLE 87: JAPAN: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 88: JAPAN: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 89: JAPAN: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 90: INDIA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 91: INDIA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 92: INDIA: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 93: ROAPAC: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 94: ROAPAC: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 95: ROAPAC: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 96: HIV INFECTIONS AND AIDS-RELATED DEATHS IN THE MIDDLE EAST AND AFRICA, 2014
  • TABLE 97: ROW: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 98: ROW: GENOME EDITING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 99: ROW: GENOME EDITING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 100: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS (2013-2016)
  • TABLE 101: PRODUCT & SERVICE LAUNCHES (2013-2016)
  • TABLE 102: ACQUISITIONS (2013-2016)
  • TABLE 103: EXPANSIONS (2013-2016)
  • TABLE 104: OTHER STRATEGIES (2013-2016)
  • TABLE 105: MARKET DEVELOPMENTS BETWEEN 2013 & 2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL GENOME EDITING MARKET SEGMENTATION
  • FIGURE 2: GLOBAL GENOME EDITING MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: GLOBAL GENOME EDITING MARKET ANALYSIS, BY TECHNOLOGY (2016-2021)
  • FIGURE 9: GLOBAL GENOME EDITING MARKET ANALYSIS, BY APPLICATION, 2016 VS. 2021
  • FIGURE 10: GLOBAL GENOME EDITING MARKET ANALYSIS, BY END USER, 2016 VS. 2021
  • FIGURE 11: GLOBAL GENOME EDITING MARKET, BY REGION, 2016 - 2021
  • FIGURE 12: GENOME EDITING MARKET PROJECTED TO WITNESS A DOUBLE-DIGIT GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 13: CELL LINE ENGINEERING SEGMENT TO DOMINATE THE GENOME EDITING MARKET IN 2016
  • FIGURE 14: CRISPR SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 15: CELL LINE ENGINEERING SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES TO COMMAND THE LARGEST MARKET SHARE IN 2016
  • FIGURE 17: NORTH AMERICA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 18: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
  • FIGURE 19: GLOBAL GENOME EDITING MARKET, BY TECHNOLOGY, 2016 VS. 2021
  • FIGURE 20: NORTH AMERICA IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF CRISPR-BASED GENOME EDITING MARKET
  • FIGURE 21: GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2016 VS. 2021
  • FIGURE 22: NORTH AMERICA IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL LINE ENGINEERING MARKET
  • FIGURE 23: GENOME EDITING MARKET, BY END USER (2016 VS. 2021)
  • FIGURE 24: GENOME EDITING MARKET, BY REGION, 2016 VS. 2021
  • FIGURE 25: NORTH AMERICA: GENOME EDITING MARKET SNAPSHOT
  • FIGURE 26: PREVALENCE OF ALZHEIMER'S DISEASE IN U.S., 2015.
  • FIGURE 27: EUROPE: GENOME EDITING MARKET SNAPSHOT
  • FIGURE 28: ASIA-PACIFIC: GENOME EDITING MARKET SNAPSHOT
  • FIGURE 29: ROW: GENOME EDITING MARKET SNAPSHOT
  • FIGURE 30: AGREEMENTS, PATNERSHIPS AND COLLABORATIONS ARE THE MAJOR STRATEGIES ADOPTED BY THE KEY PLAYERS, 2013-2016
  • FIGURE 31: MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
  • FIGURE 32: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS-KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 33: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, BY COMPANY (2013-2016)
  • FIGURE 34: PRODUCT & SERVICE LAUNCHES, BY COMPANY (2013-2016)
  • FIGURE 35: ACQUISITIONS, BY COMPANY (2013-2016)
  • FIGURE 36: EXPANSIONS, BY COMPANY (2013-2016)
  • FIGURE 37: OTHER STRATEGIES, BY COMPANY (2013-2016)
  • FIGURE 38: GEOGRAPHIC REVENUE MIX OF MARKET PLAYERS
  • FIGURE 39: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 40: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 41: SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
  • FIGURE 42: HORIZON DISCOVERY GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 43: GENSCRIPT USA INC.: COMPANY SNAPSHOT
  • FIGURE 44: SANGAMO BIOSCIENCES, INC.: COMPANY SNAPSHOT
  • FIGURE 45: LONZA GROUP LTD.: COMPANY SNAPSHOT
Back to Top